Kathleen N. Moore M.D.

Kathleen N. Moore Discusses New PARP Inhibitors for Ovarian Cancer

March 15, 2017

Kathleen N. Moore, M.D., assistant professor, Stephenson Cancer Center, The University of Oklahoma, discusses developing new PARP inhibitors for patients with ovarian cancer. These new drugs may meaningfully prolong survival from a couple months to potentially years.